PowerPoint Presentation (PDF) - Perfusion.com

More documents

Recommendations

Info

FIGURE 2. A CASE OF FULMINANT MYOCARDITIS, MANAGED USING INTRA-AORTIC BALLOON PUMPING AND MECHANICAL VENTILATOR, SHOWED THAT ON DAY 7 WHEN THE CPK LEVEL PEAKED, TH1 DOMINANT POLARITY WAS DETECTED. IN THE HEALING PHASE, AT DAY 14, T-CELLS WITH TH2 FUNCTION DRAMATICALLY INCREASED AND OVERCAME TH1 T-CELLS. AT DAY 20, BOTH TH1 AND TH2 T-CELLS DECREASED.
SUGGESTED GUIDELINES FOR CASE REPORT PRESENTATIONS Speakers for each case report will be allotted a 30-minute period on the program. You should plan to spend 20 minutes for the case report followed by a 10-minute question and answer period guided by the session moderators. This 10 -minute period is an important part of the case report under discussion and will add to the overall quality of the information conveyed. Content (at presenters discretion) may be posted on International Perfusion Association (IPA) web site. IPA is a non -profit perfusion education organization. Please sign at bottom of abstract form to exercise this option. The following guidelines are recommended from past experience to help you communicate most effectively. FORMAT • 1. Title and Introduction Each presenter should give a brief description of the case report and how it pertains to perfusion practice. • 2. Case Report The specific case should be described including: patient age, gender, and other pertinent demographics such as height, weight and body surface area, brief medical history, extracorporeal equipment and circuitry, operative and perfusion procedure, outcome and possible follow-up. • 3. Discussion This part could include evolution of the technique, history and bibliographic references. Additional experience or expansion of alternative techniques or results by other practitioners can be described. The discussion of problems, speculations or future suggested approaches should be included here. • 4. Conclusion A brief concluding statement summarizing the case with the major points should be described. • GENERAL GUIDELINES • Whenever possible, generic drug names should be used; doses of each drug should be stated when appropriate. Laboratory values should be expressed in proper units of measure. Extracorporeal equipment should be described (model number and manufacturer) to give the audience a frame of reference. Medical history of the patient should be brief and contain only information pertinent to the noteworthy aspects of the case report. The year the case was performed should be
Page 1 and 2:
A CASE REPORT: ECMO SUPPORT FOR FUL
Page 3 and 4:
MYOCARDITIS: DEFINITION • Myocard
Page 5 and 6:
CLASSIFICATION • Etiology • Ex:
Page 7 and 8:
Phase I: Viral Infection • Cardio
Page 9 and 10:
PHASE III: CELL-MEDIATED IMMUNITY
Page 11 and 12: FIGURE 1 PATHOGENESIS OF VIRAL MYOC
Page 13 and 14: HISTORY & PHYSICAL • 24 year old
Page 15: ICU AND RIGHT HEART CATH • VTach
Page 19 and 20: MUSC-ECMO •Equipment: •Stockert
Page 21: • Cardiac Stun: ECHO: DAY 1 OF EC
Page 26 and 27: ECHO: DAY 6 OF ECMO • Trial Off-
Page 28 and 29: 6 14 20 34 38 46 54 62 70 82 90 102
Page 30 and 31: fib (mg/dL) 215 191 208 229 233 306
Page 35 and 36: EF (%) 80 Patient EF Through Hospit
Page 37 and 38: CLINICAL PRESENTATION OF MYOCARDITI
Page 39 and 40: METHODS OF FM DIAGNOSIS • Echocar
Page 41 and 42: LABORATORY EVIDENCE FOR FM VS. ACUT
Page 43 and 44: Fulminant Chronic HISTOLOGICAL CLAS
Page 46: LONG-TERM OUTCOME OF FULMINANT MYOC
Page 49 and 50: EXPERIENCE AND RESULT OF ECMO IN TR
Page 51: CONCLUSION Teamwork and aggressive
Page 54 and 55: Initial Tn levels were elevated (21
Page 56 and 57: #3 JOURNAL OF THE AMERICAN COLLEGE
Page 58 and 59: FAVOURABLE CLINICAL OUTCOME IN PATI
Page 60 and 61: SPINALE IDEAS • Myocardial stanni
Page 64 and 65: CALL FOR ABSTRACTS ABSTRACTS FOR CA
show all

PowerPoint Presentation (PDF) - Perfusion.com

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?